• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Boundless Bio Presents Kinesin Degrader Data at AACR 2026

    FIRSTWORD PHARMA

    Boundless Bio to Present Preclinical Degrader Program at 2026

    GLOBENEWSWIRE

    Boundless Bio Reports Q4 & FY 2025 Results, Business Update

    GLOBENEWSWIRE

    Boundless Bio Joins Guggenheim Biotech Summit 2026

    GLOBENEWSWIRE

    Boundless Scraps Combo Treatment Of 2 Unimpressive Cancer Drugs

    FIERCE BIOTECH

    Boundless Bio To Present At Piper Sandler Healthcare Conference

    GLOBENEWSWIRE

    Boundless Bio Unveils Q3 2025 Financials & Key Achievements

    GLOBENEWSWIRE

    Boundless Bio To Present At 2025 AACR-NCI-EORTC Conference

    GLOBENEWSWIRE

    Boundless Bio to Join Goldman Sachs 46th Annual Global Healthcare

    GLOBENEWSWIRE

    Boundless Bio Prioritizes Portfolio and Extends Runway

    GLOBENEWSWIRE

    Boundless Bio at Leerink Global Healthcare Conference

    GLOBENEWSWIRE

    Boundless Bio Announces Pipeline and Leadership Updates

    GLOBENEWSWIRE

    Boundless Bio to Participate in Piper Sandler Health Conference

    GLOBENEWSWIRE

    Boundless Bio Reports Q3 2024 Financial Results & Highlights

    GLOBENEWSWIRE

    Boundless Bio Announces Departure of Chief Financial Officer

    GLOBENEWSWIRE

    Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

    GLOBENEWSWIRE

    Boundless Bio Reports Q2 2024 Results And Provides Business Updates

    GLOBENEWSWIRE

    Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

    PR NEWSWIRE

    Boundless Bio Presents Data at the AACR Annual Meeting 2024

    BUSINESSWIRE

    Boundless Bio Presents Preclinical Data on the Discovery of BBI-825

    BUSINESSWIRE

    Boundless Bio snags $100M to enter clinic by targeting circular DNA bits

    ENDPTS

    Boundless Bio Presents Data on the Novel Discovery of CHK1 as an (ecDNA)

    BUSINESSWIRE

    Boundless to Present at the 22nd Annual Needham Virtual Healthcare Conference

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.